Hester Biosciences Ltd
NSE :HESTERBIO BSE :524669 Sector : PharmaceuticalsBuy, Sell or Hold HESTERBIO? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
22 Nov 2385.45 (0.15%) | 21 Nov 2381.90 (-2.26%) | 19 Nov 2437.05 (0.23%) | 18 Nov 2431.35 (-1.03%) | 14 Nov 2456.70 (-1.60%) | 13 Nov 2496.55 (-2.76%) | 12 Nov 2567.45 (-2.85%) | 11 Nov 2642.65 (-1.14%) | 08 Nov 2673.15 (4.12%) | 07 Nov 2567.40 (5.47%) | 06 Nov 2434.30 (1.37%) | 05 Nov 2401.35 (0.09%) | 04 Nov 2399.15 (0.52%) | 01 Nov 2386.70 (1.38%) | 31 Oct 2354.25 (-1.24%) | 30 Oct 2383.85 (3.09%) | 29 Oct 2312.40 (-2.10%) | 28 Oct 2361.95 (6.14%) | 25 Oct 2225.30 (-0.20%) | 24 Oct 2229.65 (-2.42%) | 23 Oct 2284.95 (-0.48%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Very Bearish
Medium Term Investors
Neutral
Long Term Investors
Bullish
Moving Averages
5 DMA
Bearish
2419.17
10 DMA
Bearish
2504.77
20 DMA
Bearish
2426.98
50 DMA
Bearish
2406.36
100 DMA
Bearish
2515.9
200 DMA
Bullish
2082.14
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On Nov 22, 2024 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 2555.55 | 2513.75 | 2414.59 | - | - |
R2 | 2513.75 | 2473.28 | 2404.87 | 2508.16 | - |
R1 | 2449.6 | 2448.27 | 2395.16 | 2438.42 | 2481.68 |
P | 2407.8 | 2407.8 | 2407.8 | 2402.21 | 2423.84 |
S1 | 2343.65 | 2367.33 | 2375.74 | 2332.47 | 2375.73 |
S2 | 2301.85 | 2342.32 | 2366.03 | 2296.26 | - |
S3 | 2237.7 | 2301.85 | 2356.31 | - | - |
Key Metrics
EPS
37.23
P/E
63.9
P/B
6.22
Dividend Yield
0.25%
Market Cap
2,029 Cr.
Face Value
10
Book Value
382.47
ROE
7.41%
EBITDA Growth
20.96 Cr.
Debt/Equity
0.91
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Hester Biosciences Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | |
INCOME | 76.36 | 69.18 | 83.88 | 84.35 | 86.49 |
PROFIT | 4.09 | 3.98 | 4.95 | 6.34 | 8.2 |
EPS | 4.75 | 4.73 | 7.52 | 8.8 | 9.86 |
Hester Biosciences Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | |
INCOME | 67.65 | 66.49 | 74.08 | 74.52 | 74.85 |
PROFIT | 6.78 | 6.48 | 7.43 | 8.43 | 9.34 |
EPS | 7.97 | 7.61 | 8.74 | 9.91 | 10.97 |
Profit & Loss (Figures in Rs. Crores)
Hester Biosciences Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 87.16 | 104.74 | 120.21 | 145.15 | 192.89 | 205.81 | 215.41 | 259.73 | 290.9 | 311.06 | |
PROFIT | 11.6 | 19.37 | 23.62 | 25.59 | 41.61 | 28.8 | 36.62 | 39.23 | 26.62 | 18.87 | |
EPS | 15.1 | 21.71 | 26.79 | 27.12 | 47.84 | 36.44 | 40.79 | 46.41 | 32.96 | 24.88 |
Hester Biosciences Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 87.16 | 104.73 | 120.7 | 142.9 | 181.54 | 187.93 | 206.12 | 236.54 | 264.09 | 279.06 | |
PROFIT | 11.96 | 19.39 | 25.01 | 30.53 | 43.89 | 30.84 | 43.59 | 39.43 | 32.33 | 27.14 | |
EPS | 15.82 | 22.6 | 29.32 | 35.92 | 51.55 | 36.7 | 46.9 | 46.45 | 38.02 | 31.93 |
Balance Sheet (Figures in Rs. Crores)
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 |
Reserves Total | 283.29 | 271.22 | 251.48 | 219.8 | 192.57 | 168.95 | 132.13 | 113.44 | 93.2 | 76.41 |
Total Shareholders Funds | 291.8 | 279.73 | 259.99 | 228.31 | 201.08 | 177.46 | 140.64 | 121.95 | 101.71 | 84.92 |
Minority Interest | 11.08 | 8.82 | 7.41 | 7.65 | 5.42 | 3.7 | 4.37 | 4.6 | 4.65 | 2.87 |
Secured Loans | 239.04 | 268.15 | 222.57 | 104.52 | 120.68 | 79.85 | 63.52 | 56.21 | 58.91 | 54.21 |
Unsecured Loans | 5.34 | 6 | 5.6 | 5.5 | 0 | 10 | 5.26 | 10 | 0 | 0.9 |
Total Debt | 244.38 | 274.15 | 228.17 | 110.02 | 120.68 | 89.85 | 68.78 | 66.21 | 58.91 | 55.11 |
Other Liabilities | 59.17 | 34.9 | 21.55 | 18.42 | 11.35 | 0.62 | 0.05 | 0.15 | 0.15 | 0.75 |
Total Liabilities | 606.43 | 597.6 | 517.12 | 364.4 | 338.53 | 271.63 | 213.84 | 192.91 | 165.42 | 143.65 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 382.04 | 385.8 | 348.16 | 228.07 | 225.75 | 215.44 | 170.08 | 152.81 | 108.25 | 97.57 |
Less: Accumulated Depreciation | 141.93 | 126.43 | 110.99 | 95.36 | 83.5 | 70.84 | 60 | 50.33 | 43.62 | 37.97 |
Net Block | 240.11 | 259.37 | 237.17 | 132.71 | 142.25 | 144.6 | 110.08 | 102.48 | 64.63 | 59.6 |
Capital Work in Progress | 171.4 | 148.61 | 81.91 | 109.17 | 74.15 | 7.05 | 31.81 | 21.29 | 36.46 | 32.6 |
Investments | 29.93 | 25.31 | 21.24 | 0 | 0 | 0 | 0 | 0 | 0.07 | 0.28 |
Inventories | 75.58 | 84.81 | 75.38 | 62.22 | 63.97 | 50.79 | 39.76 | 33.41 | 33.62 | 29.11 |
Sundry Debtors | 78.65 | 79.63 | 55.28 | 49.21 | 58.44 | 32.87 | 32.29 | 26.53 | 26.24 | 17.76 |
Cash and Bank Balance | 15.3 | 14.82 | 25.2 | 21.27 | 23.53 | 41.05 | 13.39 | 11.48 | 5.28 | 6.58 |
Loans and Advances | 45.08 | 48.34 | 38.9 | 28.8 | 13.38 | 16.95 | 13.01 | 8.54 | 9.06 | 6.55 |
Total Current Assets | 214.61 | 227.6 | 194.77 | 161.5 | 159.31 | 141.66 | 98.45 | 79.97 | 74.2 | 60.01 |
Current Liabilities | 45.3 | 61.12 | 37.33 | 31.89 | 38.8 | 16.9 | 21.32 | 15.24 | 10.37 | 7.74 |
Provisions | 3.22 | 3.9 | 1.22 | 7.48 | 0.46 | 0.26 | 1.07 | 1.18 | 2.02 | 3.74 |
Total Current Liabilities & Provisions | 48.51 | 65.03 | 38.55 | 39.37 | 39.26 | 17.16 | 22.39 | 16.42 | 12.39 | 11.48 |
Net Current Assets | 166.1 | 162.57 | 156.22 | 122.13 | 120.05 | 124.49 | 76.06 | 63.55 | 61.81 | 48.52 |
Deferred Tax Assets | 1.22 | 1.01 | 0.75 | 0.35 | 0 | 0 | 2.28 | 5.26 | 0.03 | 0.06 |
Deferred Tax Liability | 8.63 | 8.36 | 7.26 | 7.63 | 8.82 | 10.66 | 10.1 | 8.81 | 8.06 | 5.39 |
Net Deferred Tax | -7.41 | -7.35 | -6.51 | -7.28 | -8.82 | -10.66 | -7.82 | -3.55 | -8.03 | -5.33 |
Other Assets | 6.29 | 9.09 | 27.08 | 7.67 | 10.9 | 6.14 | 3.7 | 9.14 | 10.47 | 7.97 |
Total Assets | 606.43 | 597.6 | 517.11 | 364.4 | 338.53 | 271.63 | 213.83 | 192.91 | 165.41 | 143.64 |
Contingent Liabilities | 0 | 0.2 | 0.15 | 0.15 | 0.11 | 0.11 | 0.67 | 0.62 | 0.62 | 0.56 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 |
Reserves Total | 304.21 | 283.88 | 259.93 | 229.07 | 194.57 | 170.93 | 137.57 | 113.58 | 91.81 | 75.74 |
Total Shareholders Funds | 312.72 | 292.39 | 268.44 | 237.58 | 203.08 | 179.44 | 146.08 | 122.09 | 100.32 | 84.25 |
Secured Loans | 133.56 | 164.32 | 121.91 | 15.9 | 47.9 | 28.29 | 37.62 | 29.43 | 38.66 | 37.82 |
Unsecured Loans | 0 | 0 | 0 | 0 | 0 | 10 | 5 | 10 | 0 | 0.9 |
Total Debt | 133.56 | 164.32 | 121.91 | 15.9 | 47.9 | 38.29 | 42.62 | 39.43 | 38.66 | 38.72 |
Other Liabilities | 52.96 | 26.42 | 1.63 | 0.3 | 0.15 | 0.05 | 0.05 | 0.15 | 0.15 | 0.54 |
Total Liabilities | 499.24 | 483.13 | 391.98 | 253.78 | 251.13 | 217.78 | 188.75 | 161.67 | 139.13 | 123.51 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 203.62 | 199 | 171.17 | 164.59 | 166.32 | 161.48 | 120.75 | 109.41 | 105.07 | 94.4 |
Less : Accumulated Depreciation | 100.16 | 90.78 | 86.86 | 77.95 | 69.85 | 60.88 | 54.15 | 48.7 | 43.5 | 37.87 |
Net Block | 103.46 | 108.22 | 84.31 | 86.64 | 96.47 | 100.6 | 66.6 | 60.71 | 61.57 | 56.53 |
Capital Work in Progress | 171.4 | 148.61 | 81.91 | 3.72 | 0.87 | 0.42 | 30.47 | 21.29 | 10.47 | 14.27 |
Investments | 64.69 | 64.69 | 64.69 | 43.89 | 40.67 | 28.22 | 14.48 | 8.6 | 8.67 | 8.88 |
Inventories | 68.53 | 79.22 | 70.73 | 57.01 | 60.43 | 48.5 | 38.7 | 33.07 | 33.62 | 29.11 |
Sundry Debtors | 85.78 | 82.36 | 56.92 | 45.55 | 44.76 | 32.67 | 31.94 | 26.71 | 26.24 | 17.76 |
Cash and Bank Balance | 4.96 | 5.96 | 1.98 | 1.24 | 5.19 | 2.49 | 11.95 | 11.48 | 5.26 | 4.38 |
Loans and Advances | 45.15 | 48.51 | 36.84 | 35.8 | 12.8 | 15.74 | 6.54 | 3.56 | 2.07 | 1.51 |
Total Current Assets | 204.42 | 216.05 | 166.47 | 139.61 | 123.18 | 99.4 | 89.13 | 74.82 | 67.19 | 52.77 |
Current Liabilities | 40.55 | 51.71 | 25 | 17.62 | 17.33 | 12.11 | 13.36 | 12.04 | 9.65 | 7.64 |
Provisions | 2.67 | 3.83 | 1.18 | 3.81 | 0.44 | 0.26 | 1.06 | 1.18 | 2.02 | 3.95 |
Total Current Liabilities & Provisions | 43.22 | 55.54 | 26.18 | 21.42 | 17.77 | 12.37 | 14.41 | 13.22 | 11.67 | 11.58 |
Net Current Assets | 161.19 | 160.51 | 140.3 | 118.19 | 105.41 | 87.03 | 74.72 | 61.59 | 55.52 | 41.18 |
Deferred Tax Assets | 0.96 | 0.72 | 0.46 | 0.31 | 0 | 0 | 2.18 | 5.26 | 0.03 | 0.06 |
Deferred Tax Liability | 8.05 | 7.87 | 6.75 | 7.12 | 8.29 | 10.09 | 9.51 | 8.81 | 8.06 | 5.39 |
Net Deferred Tax | -7.09 | -7.15 | -6.29 | -6.81 | -8.29 | -10.09 | -7.33 | -3.55 | -8.03 | -5.33 |
Other Assets | 5.59 | 8.25 | 27.06 | 8.17 | 15.99 | 11.61 | 9.81 | 13.02 | 10.93 | 7.97 |
Total Assets | 499.24 | 483.12 | 391.98 | 253.8 | 251.13 | 217.78 | 188.75 | 161.66 | 139.13 | 123.5 |
Contingent Liabilities | 116.77 | 115.24 | 106.45 | 103.05 | 208.44 | 27.78 | 0.67 | 0.62 | 0.62 | 0.56 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 31.95 |
Depreciation | 17.17 |
Interest (Net) | 17.56 |
P/L on Sales of Assets | -0.03 |
Prov. and W/O (Net) | 0.71 |
P/L in Forex | -0.12 |
Fin. Lease and Rental Charges | -1.18 |
Others | 26 |
Total Adjustments (PBT and Ext... | 24.22 |
Operating Profit before Workin... | 56.18 |
Trade and 0ther Receivables | 0.4 |
Inventories | 9.23 |
Trade Payables | -3.54 |
Loans and Advances | 0.13 |
Total Adjustments (OP before W... | 3.63 |
Cash Generated from/(used in) ... | 59.8 |
Direct Taxes Paid | -11.67 |
Total Adjustments(Cash Generat... | -11.67 |
Cash Flow before Extraordinary... | 48.13 |
Net Cash from Operating Activi... | 48.13 |
Sale of Fixed Assets | 0.06 |
Interest Received | 1.89 |
Net Cash used in Investing Act... | -22.5 |
Proceed from 0ther Long Term B... | 20.47 |
Of the Long Tem Borrowings | -22.97 |
Of the Short Term Borrowings | -27.51 |
Of Financial Liabilities | -0.3 |
Dividend Paid | -6.81 |
Interest Paid | -14.94 |
Net Cash used in Financing Act... | -26.05 |
Net Profit before Tax and Extr... | 36.73 |
Depreciation | 9.78 |
Interest (Net) | 2.98 |
P/L on Sales of Assets | -0.03 |
Prov. and W/O (Net) | 0.71 |
P/L in Forex | -0.12 |
Others | 26 |
Total Adjustments (PBT and Ext... | 13.32 |
Operating Profit before Workin... | 50.06 |
Trade and 0ther Receivables | -4.01 |
Inventories | 10.69 |
Trade Payables | 1.41 |
Loans and Advances | 0.16 |
Total Adjustments (OP before W... | 3.79 |
Cash Generated from/(used in) ... | 53.84 |
Direct Taxes Paid | -11.03 |
Total Adjustments(Cash Generat... | -11.03 |
Cash Flow before Extraordinary... | 42.81 |
Net Cash from Operating Activi... | 42.81 |
Sale of Fixed Assets | 0.06 |
Interest Received | 1.89 |
Net Cash used in Investing Act... | -20.63 |
Proceed from 0ther Long Term B... | 20.2 |
Of the Long Tem Borrowings | -22.82 |
Of the Short Term Borrowings | -27.55 |
Dividend Paid | -6.81 |
Interest Paid | -13.1 |
Net Cash used in Financing Act... | -24.07 |
Company Details
Registered Office |
|
Address | 1st Flr PushpakPachvati Circle, Motilal Hirabhai Road |
City | Ahmedabad |
State | Gujarat |
Pin Code | 380006 |
Tel. No. | 91-079-26445107 |
Fax. No. | 91-079-26445105 |
investor@hesterbiosciences.co.in | |
Internet | http://www.hester.in |
Registrars |
|
Address | 1st Flr PushpakPachvati Circle |
City | Ahmedabad |
State | Gujarat |
Pin Code | 380006 |
Tel. No. | 91-079-26445107 |
Fax. No. | 91-079-26445105 |
investor@hesterbiosciences.co.in | |
Internet | http://www.hester.in |
Management |
|
Name | Designation |
Bhupendra V Gandhi | Chairman (Non-Executive) |
Sanjiv D Gandhi | Non Executive Director |
Nina Gandhi | Alternate Director |
Sandhya Patel | Independent Director |
Ashok Bhadakal | Independent Director |
Ameet Desai | Independent Director |
Rajiv D Gandhi | Managing Director & CEO |
Ravin Gandhi | Non Executive Director |
PRIYA RAJIV GANDHI | Executive Director |
Anil Jain | Independent Director |
Jatin Yagneshbhai Trivedi | Independent Director |